InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Two Studies Evaluating Impact of Digital Behavioral Health Program for Teens
April 25, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has new research being published in the leading peer-reviewed journal for digital health and medicine, the “Journal of Internet Medicine.” The research is based on a quasi-randomized study that demonstrates the value of Dario’s integrated approach in providing a solution for members to manage diabetes, […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Two Contracts to Provide Integrated Cardiometabolic Solutions
April 18, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced that two employers, a national supply chain company and a regional education organization, have selected its integrated chronic condition management solutions. According to the announcement, beginning in the second quarter of 2024, Dario will provide solutions to improve outcomes for employees with […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Two Studies Evaluating Impact of Digital Behavioral Health Program for Teens
April 10, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has published two studies in the leading peer-reviewed journal for digital health and medicine, the “Journal of Internet Medicine.” The studies include a randomized controlled trial (“RCT”) demonstrating the impact of a digital stress reduction program for teens. According to the announcement, the first […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q4 2023 Results, Conference Call
April 2, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it will release its financial results for the fourth quarter ended Dec. 31, 2023, before market opens on Thursday, March 28, 2024. At 8:30 a.m. Eastern Time on that same day, the company will host a conference call and webcast. […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q4, FY 2023 Financial Report, Operational Update
March 28, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on its fourth-quarter and full-year 2023 financial results; the company also releases a corporate and commercial update. Highlights of the report include $20.4 million full-year 2023 revenue, down from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q4 2023 Results
March 21, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it will release its financial results for the fourth quarter of fiscal 2023 for the three months ended Dec. 31, 2023, on Thursday, Mar. 28, 2024, before market open. Additionally, DarioHealth’s CEO Erez Raphael and President Rick Anderson will host […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents New Research from Two Studies at International Conference
March 13, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, recently presented two new clinical studies at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”) 2024. The conference was held in Florence, Italy, on March 6–9, 2024. According to the announcement, one of the studies presented at the three-day gathering is […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Executive Team Members to Participate at Upcoming Cowen Annual Healthcare Conference
February 28, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be participating in the 44th annual Cowen Healthcare Conference. The three-day event is slated for March 4–6, 2024, in Boston. During the conference, DarioHealth CEO Erez Raphael and president Rick Anderson will be featured in a fireside chat scheduled to begin at 10:30 […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Key Acquisition, Creates Comprehensive Digital Health Platform for Chronic Conditions
February 21, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has acquired Twill Inc., a leader in digital-led care. According to the announcement, the acquisition will allow the company to “create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with Regional Union for Diabetes, Hypertension, Weight-Management, GLP-1 Support
January 11, 2024
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, announced a new contract to provide its proprietary cardiometabolic solution to a regional union. According to the announcement, the new contract is evidence that DRIO’s integrated solution to support improved whole health is gaining traction in the public and labor market. The union, which […]
InvestorNewsBreaks – DarioHealth Corp.’s (NASDAQ: DRIO) Solutions Selected by National Employer
December 5, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new contract to provide cardiometabolic and GLP-1 solutions to a national employer beginning in January 2024. The national logistics company selected Dario to deliver integrated support for employees living with diabetes, pre-diabetes, weight management and hypertension, while also providing a tailored […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Hypertension Offering Selected by Blue Shield of California
November 29, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has been selected by Blue Shield of California to expand the nonprofit health plan’s services. According to the announcement, Blue Shield of California is adding Dario’s at-home solution for high blood pressure, or hypertension, that combines personalized health coaching and tech-enabled monitoring. The addition […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks New Cardiometabolic Solution Contract with National Company
November 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has entered into a new contract outlining plans to provide is cardiometabolic solution to an employer. The contract will begin in January 2024. The new contract is the latest is a growing number of similar agreements, indicating that demand for Dario’s integrated solutions continues […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) New Research Sheds Light on Mediators of Improved Outcomes in Dario Users
November 21, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced two new analyses presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic results in Dario users. According to the announcement, presentations by Sanofi U.S. at the Diabetes Technology Society (“DTS”) annual conference, held Nov. 2 – 4, examined […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Study Showing Connection Between Increased Physical Activity, Reduced Blood Glucose
November 13, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on new research presented last week at the Diabetes Technology Society 2023 Meeting. According to the announcement, the new study demonstrates the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and prediabetes; the results emphasize […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 2023 Results
November 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the third quarter 2023 and provided a corporate and commercial update. “As we discussed during our recent investor day, our revenue generally comes from three sources, our historical direct to consumer (‘B2C’) business, recurring revenue from health plans and […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Innovative Smart Blood Glucose Meter
November 1, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced the launch of a new smart blood sugar meter for Apple iPhone 15 users to support ongoing engagement with new and existing members. As recently reported, the new iPhone 15 is built with a USB-C charging port, which is a key element […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q3 2023 Financial Results
October 30, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be releasing its financial results for Q3 2023 on Nov. 2, 2023, before the market opens. In addition, the company also announced plans to host a conference call and webcast the same day at 8:30 a.m. ET. According to the announcement, DarioHealth CEO […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Digital Health Solution Indicates Less-Costly Use of Hospital-Related Utilization, Study Shows
October 17, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on award-winning new research conducted by Sanofi U.S. that indicates the company’s ability to reduce costs through lower utilization of expensive healthcare resources. Sanofi US reported the research at the Academy of Managed Care Pharmacy’s 2023 annual conference Nexus (“AMCP-Nexus”). According to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Selected as Preferred Partner by Top Five National Employee Benefits Consulting Firm
October 5, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced a new strategic partnership with a top five national employee benefits consulting firm, to become the preferred digital health and chronic condition solution partner for its national employer clients. According to the announcement, the firm selected Dario for its proven ability to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Showcase Rise of Digital Health at Upcoming Investor Day
October 3, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced that it will host an in-person investor day in New York. The event is slated to take place beginning at 11 a.m. ET on Oct. 17, 2023, at the offices of Sullivan & Worcester LLP. Interested parties should visit https://ibn.fm/Bal6S to pre-register […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces New Research Evidencing Value of Digital Behavior Health Programs
September 27, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has announced new findings published in the Journal of Medical Internet Research (“JMIR”) demonstrating the impact of coaching and breathing exercises as part of the Dario digital behavioral health program for members living with depression or anxiety. The study analyzed the data of participants […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes New Research Backing Its Approach to Outcome-Based Engagement
August 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced new research presented at the ADCES23 Annual Conference that took place earlier this month in Houston, Texas. According to the announcement, the research demonstrates Dario’s ability to sustainably improve health outcomes for users with diabetes over a two-year period. “Dario’s solutions are […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with PlanSource to Provide Key Digital Health Solutions
August 15, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has inked a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology. The agreement, which expands Dario’s reach in the employer market, calls for the company to offer integrated digital health solutions to more than 5 million consumers. Dario’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 2023 Results
August 10, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the second quarter 2023 and provided a corporate and commercial update. “During the second quarter, we saw a continuation of the many positive trends that have contributed to our improved financial profile, including growing revenue contribution from highly scalable […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Agreement with Large Regional Health Plan
August 8, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced the expansion of its partnership with a large regional health plan to deliver highly personalized digital health solutions to plan members living with diabetes. The launch is anticipated to take place in the first quarter of 2024. “Our ability to engage members […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q2 2023 Results, Conference Call and Webcast
August 3, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the second quarter ended June 30, 2023, before market opens on Thursday, Aug. 10, 2023. Also on Aug. 10, the company will host a conference call and webcast at 8:30 a.m. Eastern Time, led […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Behavior Program to Support Weight Loss, Better Health
August 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is offering a new program designed to provide support for individuals using GLP-1s and other anti-obesity drugs. The program is designed to support changes in behavior and help users leverage the full potential of medications while improving overall health; the program also has potential […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Shares New Research Supporting Significant Medical Costs Savings for Dario Users
July 26, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced a new analysis by Sanofi U.S. demonstrating a significant reduction in the cost of care for Dario users compared to non-users living with type 2 diabetes. According to the announcement, the study used matched claims to show an estimated $5,077 in medical […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Large Regional Health Plan to Client List, Reports on Q2 2023 Preliminary Results
July 24, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has added a new agreement with a large regional health plan to its client list. According to the announcement, DRIO will deliver highly personalized digital health solutions to more than 160,000 plan members living with hypertension; the plan will launch this month. DRIO noted […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds New Full-Suite Employer to Growing Number of Contracts
July 6, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is adding a new employer contract to its growing list of clients. The new full-suite account is scheduled to launch later this year, and the company expects it to add to revenue for the year. According to the company, the new account is a […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Key Research Presented at ABA Scientific Sessions
June 26, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, reported on a retrospective cohort study at the recent American Diabetes Association (“ABA”) 83rd Scientific Sessions. According to the announcement, the study analyzed real-world data of Dario users against matched controls, with results showing significant improvements in HbA1c for Dario users with serious diabetes. […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Two New Contracts for Integrated Solutions
June 7, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced two new employer contracts for the company’s full suite of integrated solutions. According to the update, the new accounts are scheduled to launch in the second half of 2023. “Managing the rising cost of chronic conditions with a significant return on investment […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO to Present at Upcoming Stifel Virtual Cross Sector Insight Conference
June 1, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be attending and participating in the Stifel 2023 Virtual Cross Sector Insight Conference. The two-day event is scheduled to be held in Boston on June 6–7, 2023. According to the announcement, DarioHealth president Rick Anderson will be presenting at the conference; his presentation […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Solutions to MedOne Members
May 18, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global health market, and MedOne Pharmacy Benefit Solutions (“PBM”), a national leader in modern pharmacy benefits management, today announced a new agreement to integrate Dario’s suite of digital health solutions as a complement to MedOne’s digital diabetes solution, the Diabetes Care Path. According to the update, the collaboration […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q1 Financial and Operating Results
May 11, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced financial results for the first quarter 2023 and provided a corporate and commercial update. “During the first quarter, we continued to improve the financial profile of the company as we capitalized on the growing demand for digital health solutions in the […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Research Presented at Leading Global Conference for Health Economics
May 9, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, announced the presentation of research at ISPOR 2023, the leading global conference for health economics and outcomes research. The conference was on May 7–10, 2023, in Boston. The research presented came from a retrospective cohort study that analyzed real-world data of users and nonusers […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Upcoming Release of Q1 2023 Financial Results, Schedules Earnings Call
May 4, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, plans to reports on its financial results for the first quarter ended March 31, 2023; the company will release the report on May 11, 2023, before market open. In addition, DarioHealth has scheduled an earnings conference call and webcast to discuss the report. The event […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Private Placement Pricing, Announces Credit Facility Refinance
May 2, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced the pricing of a $14.3 million private placement of convertible preferred stock. The announcement noted that the placement had been priced at the market under NASDAQ rules and included “significant participation by select members of leadership, the board and existing investors.” In addition, DarioHealth […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Appoints Digital Health Product Leader as Chief Product Officer
April 4, 2023
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that digital health veteran, Eitan Shay, is joining the company in the newly created position of chief product officer. Shay previously served in product leadership roles at digital health companies Livongo and Teladoc Health, as well as senior leadership roles at […]